Masimo (MASI) Scheduled to Post Quarterly Earnings on Tuesday

Masimo (NASDAQ:MASI) is scheduled to post its quarterly earnings results after the market closes on Tuesday, February 27th. Analysts expect Masimo to post earnings of $0.61 per share for the quarter.

Shares of Masimo (NASDAQ:MASI) opened at $86.68 on Tuesday. The company has a market cap of $4,480.00, a P/E ratio of 13.74, a PEG ratio of 3.29 and a beta of 0.85. Masimo has a 52-week low of $80.69 and a 52-week high of $104.71.

In other news, EVP Yongsam Lee sold 18,198 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $88.85, for a total transaction of $1,616,892.30. Following the completion of the sale, the executive vice president now owns 70,800 shares of the company’s stock, valued at approximately $6,290,580. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Sanford Fitch sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 25th. The stock was sold at an average price of $90.00, for a total transaction of $180,000.00. Following the sale, the director now directly owns 70,249 shares of the company’s stock, valued at approximately $6,322,410. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 48,098 shares of company stock valued at $4,315,261. Insiders own 13.10% of the company’s stock.

Several analysts have recently commented on the stock. Zacks Investment Research downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 7th. BidaskClub downgraded shares of Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 price objective on shares of Masimo in a research report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. Masimo presently has an average rating of “Hold” and an average target price of $104.60.

TRADEMARK VIOLATION WARNING: This story was first reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.thelincolnianonline.com/2018/02/20/masimo-masi-scheduled-to-post-quarterly-earnings-on-tuesday.html.

Masimo Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Earnings History for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply